Lipohypertrophy

Introduction

Lipohypertrophy is localized enlargement of fat tissue, most often at sites where insulin is injected repeatedly. The area may feel rubbery or firm, look swollen or lumpy, and become less sensitive—so people keep injecting there without noticing the problem.

It is more than a cosmetic issue. Injecting into lipohypertrophic tissue can make insulin absorption unpredictable, causing unexplained high or low blood glucose and frustrating diabetes control.

The main drivers are repeated trauma to the same site, poor site rotation, and sometimes needle reuse. Diagnosis is usually clinical; ultrasound can help when the exam is unclear.

This page covers causes, symptoms, evaluation, treatment, prevention, complications, and when to seek care. It is general education—not a personal diabetes plan.

Overview

Lipohypertrophy is common among people who use insulin, especially when education on rotation and needle technique is limited. Older age, female sex in some studies, and poorly controlled diabetes are associated with higher risk.

Unlike a simple bruise, the lump is thickened adipose tissue that may persist for months. Unlike a lipoma, it is typically tied to injection history and often improves when that site is rested.

Early recognition, site maps, and technique coaching usually restore more predictable insulin action and reduce the need for dose guessing.

• Localized fatty lumps at insulin injection sites
• Interferes with consistent insulin absorption
• Driven mainly by repeated injections in one spot
• Clinical diagnosis; ultrasound sometimes used
• Primary fix: stop injecting into affected areas and rotate sites
• Severe persistent masses may need surgical removal

What happens in the body

Repeated needle trauma and local insulin effects stimulate adipocyte hypertrophy and fibrosis in the subcutaneous layer. The resulting tissue has altered blood flow, so depot insulin is absorbed irregularly.

Patients often prefer painless thickened sites, creating a cycle of further injury. Infection is not required for lipohypertrophy to form, though skin trauma can raise infection risk separately.

• Chronic microtrauma at injection sites
• Local adipose hypertrophy and tissue change
• Erratic insulin pharmacokinetics → glucose swings
• No specific infectious cause identified
• Improvement after prolonged site rest is common

Signs and symptoms

Typical features at or near injection sites include:

• Visible or palpable fatty lumps or bumps
• Thickened, rubbery, or discolored overlying skin
• Tenderness or discomfort in the affected area
• Unexplained blood-glucose swings despite “correct” doses
• Preference for injecting the same painless spot
• Delayed or exaggerated insulin effect after injecting into the lump
• Rapid glucose changes that seem out of proportion to meals or activity
• Severe pain or swelling at an injection site (needs urgent review)
• Redness, warmth, or pus suggesting infection
• Psychosocial distress about appearance of injection sites

Causes and risk factors

Insulin technique is the main driver; additional contributors include:

• Repeated insulin injections into the same site
• Inadequate site rotation across abdomen, thighs, buttocks, and arms as advised
• Reusing needles or poor injection technique
• Older age with thinner or less elastic skin
• Female sex in some observational series
• Poorly controlled diabetes and frequent dosing adjustments
• High-calorie, low-nutrient diet contributing to overall adiposity
• Sedentary lifestyle worsening metabolic health
• Limited education or access to injection training
• Possible individual susceptibility to abnormal fat response (evidence limited)

Diagnosis and evaluation

Most cases are diagnosed by history and careful palpation of injection zones:

• History of insulin use, sites, needle length/reuse, and glucose patterns
• Exam of all usual injection areas for firmness, size, and sensation
• Blood glucose review and overall metabolic assessment
• Ultrasound when extent is unclear or another mass is suspected
• Differential diagnosis: lipoma, lipoedema, abscess, or other soft-tissue swellings

Treatment and management

There is no specific drug for lipohypertrophy; technique change is first-line:

• Stop injecting into affected sites until the tissue softens (often weeks to months)
• Systematic rotation of fresh sites with a written or app-based site map
• Insulin regimen review with a clinician or diabetes educator to stabilize doses after absorption improves
• Use a new needle for each injection when possible; follow recommended needle length and angle
• Balanced diet and regular activity to support weight and metabolic health
• Surgical excision only for severe, persistent, or functionally problematic masses
• Pediatric and geriatric adjustments for dosing, skin thickness, and caregiver technique
• Adjunct massage or other comfort measures only as advised—do not replace medical care

Prevention, self-care, and lifestyle

Not every condition is fully preventable, but the steps below may lower risk or recurrence:

• Rotate injection sites systematically and leave previously used spots to recover
• Learn and refresh proper injection technique with a diabetes educator
• Avoid needle reuse and check sites regularly by sight and touch
• Maintain hygiene at injection sites to reduce infection risk
• Keep vaccinations current as advised for overall infection prevention
• Monitor glucose closely after changing sites—absorption may improve and doses may need adjustment with clinical guidance
• Support healthy weight with diet and activity

Possible complications

Delay, missed care, or unsafe self-medication can raise the chance of complications in some cases:

• Erratic glucose control and higher risk of hypoglycemia or hyperglycemia
• Greater long-term diabetes complication risk if control stays poor
• Local infection from repeated skin trauma
• Pain, scarring, and body-image concerns
• Unnecessary insulin dose escalation while injecting into damaged tissue

When to see a doctor or seek emergency care

Seek prompt medical advice or emergency care if any of the following apply—it is safer not to wait and see:

• Rapid or unexplained swings in blood glucose
• Severe pain or swelling at an injection site
• Signs of infection: redness, warmth, pus, or fever
• Lumps that enlarge, harden, or do not improve after resting the site
• Difficulty managing diabetes after changing injection habits—seek educator or clinician support

Living with the condition

Treat site rotation as part of every injection routine, not an optional tip. Many people need a printed body map until the habit sticks.

Expect glucose patterns to change when you stop using lipohypertrophic areas—check more often and adjust doses only with clinical advice.

With early change, lipohypertrophy often softens and insulin action becomes more predictable again.

Frequently asked questions

What causes lipohypertrophy?

Most often repeated insulin injections in the same place; diet and lifestyle may contribute to overall fat health but are secondary.

How can I prevent it?

Rotate sites, use good technique, avoid needle reuse, keep sites clean, and review injection habits regularly.

Is it reversible?

Often yes—resting the area and correcting technique usually helps; surgery is reserved for stubborn cases.

Can it affect diabetes management?

Yes. Absorption from lipohypertrophic tissue is unreliable and can cause high and low glucose swings.

Are there medicines specifically for lipohypertrophy?

No specific drug treats the lumps; optimizing insulin delivery and lifestyle is the main approach.

Is it common in people who use insulin?

Yes, especially when site rotation is inconsistent.

When should I see a doctor?

For severe site pain, infection signs, rapid glucose changes, or lumps that do not improve with site rest.

Can lifestyle changes help?

Balanced eating, activity, and healthy weight support overall metabolic health alongside proper injection technique.

Important caution

This article is general health education in English. It is not personal medical advice, a prescription, a lab report interpretation, or a promise about hospital costs.

Every patient is different. Decisions about medicines, tests, or surgery should follow evaluation by a qualified clinician.

If symptoms are severe, rapidly worsening, or you are at higher risk (child, pregnant, older adult, immunocompromised, or living with multiple chronic diseases), seek care without delay.